MedPath

PMS-FUROSEMIDE

PMS-FUROSEMIDE

Dormant
DIN Number

02247493

Drug Class

Human

Market Date

Dec 10, 2003

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02247493
AIG Number0101944002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C03CA01 FUROSEMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:28.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

FUROSEMIDEActive
Strength: 20 MG
Monograph: FUROSEMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.